Progression of aortic dilatation and the benefit of long-term beta-adrenergic blockade in Marfan's syndrome.
about
Beta-blockers for preventing aortic dissection in Marfan's syndromeFirst-line beta-blockers versus other antihypertensive medications for chronic type B aortic dissectionFirst-line beta-blockers versus other anti-hypertensive medications for chronic type B aortic dissectionsLosartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndromeMarfan's syndromeThe molecular genetics of Marfan syndrome and related microfibrillopathiesA Case Based Approach to Clinical Genetics of Thoracic Aortic Aneurysm/Dissection.Marfan syndrome: current perspectivesMedical treatment of aortic aneurysms in Marfan syndrome and other heritable conditionsEducational paper. Connective tissue disorders with vascular involvement: from gene to therapyPerspectives on the revised Ghent criteria for the diagnosis of Marfan syndromeAngiotensin II blockade and aortic-root dilation in Marfan's syndromeAng II enhances noradrenaline release from sympathetic nerve endings thus contributing to the up-regulation of metalloprotease-2 in aortic dissection patients' aorta wallCardiovascular magnetic resonance in Marfan syndrome.Rationale and design of a randomized clinical trial of beta-blocker therapy (atenolol) versus angiotensin II receptor blocker therapy (losartan) in individuals with Marfan syndromeMarfan's syndrome and the heart.Detection of abnormal aortic elastic properties in asymptomatic patients with Marfan syndrome by combined transoesophageal echocardiography and acoustic quantification.Insurance status is associated with acuity of presentation and outcomes for thoracic aortic operations.Marfan syndrome.Role of beta-blockers in Marfan's syndrome and bicuspid aortic valve: A time for re-appraisal.The Genetics of Aortopathies in Clinical Cardiology.Canadian Cardiovascular Society 2009 Consensus Conference on the management of adults with congenital heart disease: outflow tract obstruction, coarctation of the aorta, tetralogy of Fallot, Ebstein anomaly and Marfan's syndromeA locus for autosomal dominant mitral valve prolapse on chromosome 11p15.4.Natural history of cardiovascular manifestations in Marfan syndrome.Penetrating aortic ulcers after absorption of intramural hematomaReport of the National Heart, Lung, and Blood Institute and National Marfan Foundation Working Group on research in Marfan syndrome and related disorders.Loeys-Dietz syndrome: a primer for diagnosis and management.Drug-based therapies for vascular disease in Marfan syndrome: from mouse models to human patients.The diagnosis and management of aortic dissection.Marfan syndrome and pregnancy: maternal and neonatal outcomes.Associations of high myopia in childhood.Matrix metalloproteinases: from biology to therapeutic strategies in cardiovascular disease.A prospective, randomized, placebo-controlled, double-blind, multicenter study of the effects of irbesartan on aortic dilatation in Marfan syndrome (AIMS trial): study protocol.Local pulse pressure is a major determinant of large artery remodelling.Post-stenotic aortic dilatation.Marfan syndrome: an update of genetics, medical and surgical management.Management of Marfan syndrome.Current insights in diagnosis and management of the cardiovascular complications of Marfan's syndrome.Insurance status predicts acuity of thoracic aortic operationsβ-Blockers and angiotensin converting enzyme inhibitors: comparison of effects on aortic growth in pediatric patients with Marfan syndrome
P2860
Q24194883-618795F7-5FD3-4D27-A7EB-1BAD09F78096Q24200255-EC3B3BB1-3ED3-4C90-BC91-B78A63727091Q24200438-E33699B7-627F-476D-869A-32B50AA308A3Q24548457-9CB2A014-7A5F-41F6-9990-BD321D4C25E7Q24553344-0AC5B6A2-6251-49BD-BDFD-743F959C7769Q24681593-D27EBCE3-6E09-463F-88B9-0B194FCF3D5DQ26744537-9677DAAB-74D1-49E9-909A-1097833B69B2Q26747739-7D522B02-3206-42C2-8FDA-37EC7A37044BQ26823672-38AC4998-A73A-4B66-9492-73824BA52439Q26853455-9517A197-96A8-4031-99D0-CE62FB1AC89AQ26864278-0DA39A05-B58C-4223-83E3-8C6FBBE13D5FQ28285199-10D24359-8020-4050-B799-A59E818A0973Q28534594-C0FF091C-6D4B-4EEE-AC83-9F312BBEB1B1Q30454633-02ED8C8B-DFE9-46C9-988E-C86289403CF5Q30476899-9EEFC844-465B-41A5-ACC1-852DAAE62A2AQ30482248-629EE1BB-699D-4A8B-A55D-AAD6E789EC0AQ30535299-22FAE06B-5F43-4DF2-97C6-A36B801AC5F8Q33650995-1AC29612-27D8-494C-8E78-36F00A5AA2F7Q33677345-670DC327-0DC4-4FDC-B6D2-ED9887A6933EQ33735728-88232A6B-574F-441D-B793-1948FF6AD767Q33758342-E7092C1F-16EB-48E4-8C47-C6378119F3EBQ33776426-F6E65C0D-CF85-4B50-94E0-DDB742A4D3AAQ33904900-1F0AFFB1-7532-402E-8879-59B4B6FE1D1EQ33931523-029AB1A9-B5D3-4EE7-A920-F6D47D1F6433Q33935543-D58C022C-C35D-4063-B4E9-F06C464FBBFEQ34017755-7E72D2D3-0F5D-4C4D-BAA4-B35D129C82C6Q34038144-DEC56D76-8EE3-4AE7-94ED-AE81F34BC569Q34051477-84FCF437-FD11-4530-882A-51D56B946805Q34105909-2DE5E934-63CB-40F6-96A0-B8ECCC047FB4Q34174696-0C7923B2-15EE-4B49-8FA4-D631F316DDF9Q34229188-1D02A1BC-99E2-4EC2-A16E-9358295EBAD2Q34347211-DCE244C0-4E09-41B6-BFDD-65342FC76528Q34455509-AAE4FB1A-D14B-47DC-A4F5-9908A9E7CDCFQ34570423-B1394AEC-E862-4988-BAEA-5DB12568CFC1Q34624744-36C92813-F9E5-4F0E-9E76-CA17D45FD2E8Q34628332-A9472A7F-DC62-46C4-992B-818A9D1CF3BBQ34688776-507EEA62-DEC0-4CC7-A37E-341E3E324D46Q34806881-907E29DA-EFFB-4DF4-A46A-97C526E95368Q35067122-5E67674D-F8F2-4553-B378-D2B6A1196C0BQ35089538-79B7018E-8FD5-4776-AEF9-09255BFC550B
P2860
Progression of aortic dilatation and the benefit of long-term beta-adrenergic blockade in Marfan's syndrome.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年学术文章
@wuu
1994年学术文章
@zh
1994年学术文章
@zh-cn
1994年学术文章
@zh-hans
1994年学术文章
@zh-my
1994年学术文章
@zh-sg
1994年學術文章
@yue
1994年學術文章
@zh-hant
name
Progression of aortic dilatati ...... blockade in Marfan's syndrome.
@en
Progression of aortic dilatati ...... blockade in Marfan's syndrome.
@nl
type
label
Progression of aortic dilatati ...... blockade in Marfan's syndrome.
@en
Progression of aortic dilatati ...... blockade in Marfan's syndrome.
@nl
prefLabel
Progression of aortic dilatati ...... blockade in Marfan's syndrome.
@en
Progression of aortic dilatati ...... blockade in Marfan's syndrome.
@nl
P2093
P1476
Progression of aortic dilatati ...... blockade in Marfan's syndrome.
@en
P2093
P304
P356
10.1056/NEJM199405123301902
P407
P577
1994-05-01T00:00:00Z